You are here

Home

Biblio

[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Lee J, Khobragade PY, Banerjee J, Chien S, Angrisani M, Perianayagam A, Bloom DE, Dey AB.  2020.  Design and Methodology of the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD).. J Am Geriatr Soc. 68 Suppl 3:S5-S10.
Lee J, Ganguli M, Weerman A, Chien S, Lee DYoung, Varghese M, Dey AB.  2020.  Online Clinical Consensus Diagnosis of Dementia: Development and Validation.. J Am Geriatr Soc. 68 Suppl 3:S54-S59.
Lee J, Dey AB.  2020.  Introduction to LASI-DAD: The Longitudinal Aging Study in India-Diagnostic Assessment of Dementia.. J Am Geriatr Soc. 68 Suppl 3:S3-S4.
Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J, Hardy J, Escott-Price V.  2019.  Polygenic risk and hazard scores for Alzheimer's disease prediction.. Ann Clin Transl Neurol. 6(3):456-465.
Leung YYee, Valladares O, Chou Y-F, Lin H-J, Kuzma AB, Cantwell L, Qu L, Gangadharan P, Salerno WJ, Schellenberg GD et al..  2018.  VCPA: genomic Variant Calling pipeline and data management tool for Alzheimer's Disease Sequencing Project.. Bioinformatics.
Li Z, Farias FHG, Dube U, Del-Aguila JL, Mihindukulasuriya KA, Fernández MVictoria, Ibañez L, Budde JP, Wang F, Lake AM et al..  2020.  The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.. Acta Neuropathol. 139(1):45-61.
Lin H, Satizabal C, Xie Z, Yang Q, Huan T, Joehanes R, Wen C, Munson PJ, Beiser A, Levy D et al..  2017.  Whole blood gene expression and white matter Hyperintensities.. Mol Neurodegener. 12(1):67.
Liu Y, Wang M, Marcora EM, Zhang B, Goate AM.  2019.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.. Neurosci Lett. 711:134403.
Lo M-T, Kauppi K, Fan C-C, Sanyal N, Reas ET, Sundar VS, Lee W-C, Desikan RS, McEvoy LK, Chen C-H.  2019.  Identification of genetic heterogeneity of Alzheimer's disease across age.. Neurobiol Aging. 84:243.e1-243.e9.
Lobach I, Kim I, Alekseyenko A, Lobach S, Zhang L.  2019.  A simple approximation to bias in the genetic effect estimates when multiple disease states share a clinical diagnosis.. Genet Epidemiol. 43(5):522-531.
Lyon MS, Andrews SJ, Elsworth B, Gaunt TR, Hemani G, Marcora E.  2021.  The variant call format provides efficient and robust storage of GWAS summary statistics.. Genome Biol. 22(1):32.
Lyons CE, Zhou X, Razzoli M, Chen M, Xia W, Ashe K, Zhang B, Bartolomucci A.  2021.  Lifelong chronic psychosocial stress induces a proteomic signature of Alzheimer's disease in wildtype mice.. Eur J Neurosci.
M
Ma Y, Jun GR, Zhang X, Chung J, Naj AC, Chen Y, Bellenguez C, Hamilton-Nelson K, Martin ER, Kunkle BW et al..  2019.  Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype.. JAMA Neurol.
Ma Y, Jun GR, Chung J, Zhang X, Kunkle BW, Naj AC, White CC, Bennett DA, De Jager PL, Mayeux R et al..  2019.  CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.. Aging Cell. 18(4):e12964.
Madrid L, Moreno-Grau S, Ahmad S, González-Perez A, de Rojas I, Xia R, Adami PVMartino, García-González P, Kleineidam L, Yang Q et al..  2021.  Multiomics integrative analysis identifies allele-specific blood biomarkers associated to Alzheimer's disease etiopathogenesis.. Aging (Albany NY). 13(7):9277-9329.
Malik R, Georgakis MK, Neitzel J, Rannikmäe K, Ewers M, Seshadri S, Sudlow CLM, Dichgans M.  2021.  Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank.. Alzheimers Dement. 17(9):1422-1431.
Mandaviya PR, Joehanes R, Brody J, Castillo-Fernandez JE, Dekkers KF, Do AN, Graff M, Hänninen IK, Tanaka T, de Jonge EAL et al..  2019.  Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation in blood: a large-scale epigenome-wide association analysis in 5841 individuals.. Am J Clin Nutr. 110(2):437-450.
Marca-Ysabel MVictoria, Rajabli F, Cornejo-Olivas M, Whitehead PG, Hofmann NK, Manrique MZaida Illa, Otani DMartin Vel, Neyra AKarina Mil, Suarez SCastro, Vega MMeza et al..  2021.  Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.. Neurobiol Aging. 101:298.e11-298.e15.
Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, W Hill D, Davies G, Ritchie CW, Gale CR, Starr JM et al..  2018.  GWAS on family history of Alzheimer's disease.. Transl Psychiatry. 8(1):99.
Martin ER, Gao XR, Li Y-J.  2021.  An exploration of genetic association tests for disease risk and age at onset.. Genet Epidemiol. 45(3):249-279.
McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL et al..  2020.  Circulating ceramide ratios and risk of vascular brain aging and dementia.. Ann Clin Transl Neurol.
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS et al..  2019.  Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.. PLoS One. 14(3):e0213321.
Mishra A, Chauhan G, Violleau M-H, Vojinovic D, Jian X, Bis JC, Li S, Saba Y, Grenier-Boley B, Yang Q et al..  2019.  Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects.. Brain. 142(4):1009-1023.
Mock C, Teylan M, Beecham G, Besser L, Cairns NJ, Crary JF, Katsumata Y, Nelson PT, Kukull W.  2020.  The Utility of the National Alzheimer's Coordinating Center's Database for the Rapid Assessment of Evolving Neuropathologic Conditions.. Alzheimer Dis Assoc Disord. 34(2):105-111.
Moreno-Grau S, Fernández MVictoria, de Rojas I, García-González P, Hernández I, Farias F, Budde JP, Quintela I, Madrid L, González-Perez A et al..  2021.  Long runs of homozygosity are associated with Alzheimer's disease.. Transl Psychiatry. 11(1):142.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer